secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kura Oncology, Inc. (KURA)
CIK:        0001422143
Form:       8-K
Filed at:   2023-12-22T23:59:59+00:00
Accession:  0001193125-23-301830
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kura Oncology adopts 2023 Inducement Option Plan reserving 600,000 shares for new hires
--------------------------------------------------------------------------------

- Plan reserves 600,000 shares of common stock for nonstatutory stock option grants to new employees as inducement material to employment.
- Awards must be approved by a majority of independent directors or independent compensation committee per Nasdaq Rule 5635(c)(4).
- Plan terms are substantially similar to the company's stockholder-approved Amended and Restated 2014 Equity Incentive Plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1422143/000119312523301830/0001193125-23-301830-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1422143/000119312523301830/d675636d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-301830

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer